Barnes Wealth Management Group’s AbbVie ABBV Stock Holding History

Barnes Wealth Management Group’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$341K	Sell	1,355 -15	-1%	-$3.23K	0.16%	131
2026 Q1	$298K	Buy	1,370 +33	+2%	+$7.32K	0.15%	136
2025 Q4	$305K	Buy	1,337 +67	+5%	+$15.3K	0.16%	124
2025 Q3	$294K	Sell	1,270 -88	-6%	-$17.9K	0.16%	123
2025 Q2	$252K	Buy	1,358 +38	+3%	+$7.06K	0.15%	130
2025 Q1	$277K	Buy	1,320 +59	+5%	+$11.5K	0.18%	113
2024 Q4	$224K	Buy	+1,261	New	+$232K	0.15%	127

Other funds holding ABBV

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

HCM

Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

FWCM

Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return

AAIS

ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return

Barnes Wealth Management Group's ABBV Position: Q2 2026 in Review

Barnes Wealth Management Group reduced its AbbVie (ABBV) stake by 1.1% in Q2 2026, selling an estimated $3.23K and leaving 1,355 shares worth $341K. The position accounts for 0.16% of the portfolio, ranked #131.

Barnes Wealth Management Group first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. 1,602 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Barnes Wealth Management Group held 1,355 shares of AbbVie worth $341K as of Q2 2026.
Barnes Wealth Management Group sold 15 AbbVie shares in Q2 2026, an estimated $3.23K.
AbbVie made up 0.16% of Barnes Wealth Management Group's portfolio in Q2 2026, its #131 holding.
Barnes Wealth Management Group first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
1,602 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Barnes Wealth Management Group's 13F filing for Q2 2026, filed 24 Jul 2026.